CRIS - Strong Double BottomsRecurring Double Bottom patterns are evident
Once price completes its current double bottom 1.70 is a good target for price to aim for
0%
0%
0%
0%
0%
−0.5026USD
−56.672MUSD
10.162MUSD
117.705M
About Curis, Inc.
Sector
Industry
CEO
James E. Dentzer
Website
Headquarters
Lexington
Employees
51
Founded
2000
ISIN
US2312692005
Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
Cris Although it had nic rip off support of a larger pattern with another test of the mid term downward resiatnce I am looking to potentially scoop some up. I really want to see how we react at this 7.60$ level holding as support. Might be worth a buy attempt. Targets of 10$+ howver the Key breakout le
CRIS Primed for a reversalThe technicals are in favor for a bullish run. with a major gap to fill near 11.94. I think we see a positive run in the coming days
Big Winners For Monday 6/12/21 According To My AIThis is my top 10 estimates for the highs of the day on Monday (6/12/2021) according to my AI program and for those users that have been following my ai idea updates, I have improved the ai quite a bit to provide much more accurate results and I have implemented a scoring system that ranges from +30
CURIS STOCKIf we hold, we have a double bottom in play. This could lead to filling the gap that has occurred. Look for institutions to treat this as the Demand zone. The recent sell off was the supply zone.
CRIS - Daily chart analysisNot much to say about this. Prime example of what happens when top resistance breaks.
NO POSITION.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
